Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk
Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk Justin Heinonen and John Spink, 2010 Despite the potentially staggering economic, public safety, and health impact of product counterfeiting generally and pharmaceutical counterfeiting specifically, there are virtually no reliable, systemic data on the problem and no publicly available sources for detailed information on incidents. To …
Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk Read More »